AAMI 11135 2014
$162.84
ANSI/AAMI/ISO 11135:2014 – Sterilization of health care products-Ethylene oxide-Requirements for development, validation and routine control of a sterilization process for medical devices
Published By | Publication Date | Number of Pages |
AAMI | 2014 | 95 |
Specifies requirements for the development, validation, and routine control of an ethylene oxide sterilization process for medical devices.
PDF Catalog
PDF Pages | PDF Title |
---|---|
1 | ANSI/AAMI/ISO 11135:2014, Sterilization of health care products —Ethylene oxide —Requirements for development, validation and routine control of a sterilization process for medical devices |
2 | Objectives and uses of AAMI standards and recommended practices |
3 | Title page |
4 | AAMI Standard Copyright information |
5 | Contents |
8 | Glossary of equivalent standards |
9 | Committee representation |
12 | Background of ANSI/AAMI adoption of ISO 11135:2014 |
13 | Foreword |
14 | Introduction |
17 | 1 Scope 1.1 Inclusions 1.2 Exclusions |
18 | 2 Normative references |
19 | 3 Terms and definitions |
27 | 4 Quality management systems 4.1 Documentation 4.2 Management responsibility 4.3 Product realization 4.4 Measurement, analysis and improvement — Control of nonconforming product |
28 | 5 Sterilizing agent characterization 5.1 General 5.2 Sterilizing agent 5.3 Microbicidal effectiveness 5.4 Material effects 5.5 Safety and the environment 6 Process and equipment characterization 6.1 General |
29 | 6.2 Process characterization |
30 | 6.3 Equipment characterization |
31 | 7 Product definition 7.1 General 7.2 Product safety, quality and performance 7.3 Microbiological quality |
32 | 7.4 Documentation 8 Process definition |
33 | 9 Validation 9.1 General 9.2 Installation qualification, IQ 9.2.1 Equipment 9.2.2 Installation qualification |
34 | 9.3 Operational qualification, OQ 9.4 Performance qualification, PQ 9.4.1 General |
35 | 9.4.2 Performance qualification — Microbiological 9.4.3 Performance qualification — Physical |
36 | 9.5 Review and approval of validation |
38 | 10 Routine monitoring and control |
40 | 11 Product release from sterilization 12 Maintaining process effectiveness 12.1 General 12.2 Maintenance of equipment |
41 | 12.3 Requalification 12.4 Assessment of change 12.5 Assessment of equivalence 12.5.1 Process equivalence |
42 | 12.5.2 Product |
43 | Annex A: Determination of lethal rate of the sterilization process — Biological indicator/bioburden approach A.1 General A.2 Procedure |
44 | Annex B: Conservative determination of lethal rate of the sterilization process — Overkill approach B.1 General B.2 Procedure |
46 | Annex C: Temperature sensors, RH sensors and biological indicator numbers C.1 Temperature sensors Table C.1 — Minimum recommended number of temperature sensors |
47 | C.2 Humidity sensors Table C.2 — Minimum recommended number of humidity sensors C.3 Biological Indicators |
48 | Table C.3 — Examples of minimum recommended number of BI/PCDs |
49 | Annex D: Guidance on the application of the normative requirements D.1 Scope D.2 Normative references D.3 Terms and definitions D.4 Quality management systems D.4.1 Documentation D.4.2 Management responsibility |
50 | D.4.3 Product realization D.4.4 Measurement, analysis and improvement — Control of non-conforming product D.5 Sterilizing agent characterization D.5.1 General |
51 | D.5.2 Sterilizing agent D.5.3 Microbicidal effectiveness D.5.4 Material effects D.5.5 Safety and the environment |
52 | D.6 Process and equipment characterization D.6.1 General D.6.2 Process characterization |
54 | D.6.3 Equipment characterization |
56 | D.7 Product definition D.7.1 General |
59 | D.7.2 Product safety, quality and performance |
61 | D.7.3 Microbiological quality D.7.4 Documentation D.8 Process definition |
65 | D.9 Validation D.9.1 General D.9.2 Installation qualification D.9.2.1 Equipment |
66 | D.9.2.2 Installation qualification |
67 | D.9.3 Operational qualification |
69 | D.9.4 Performance qualification D.9.4.1 General |
70 | D.9.4.2 Performance qualification — Microbiological |
71 | D.9.4.3 Performance qualification — Physical |
72 | D.9.4.4 Review and approval of validation |
73 | D.10 Routine monitoring and control |
76 | D.11 Product release from sterilization D.12 Maintaining process effectiveness D.12.1 General |
77 | D.12.2 Maintenance of equipment |
78 | D.12.3 Requalification |
80 | Figure D.1 — Requalification decision tree D.12.4 Assessment of change |
81 | D.12.5 Assessment of equivalence1F** D.12.5.1 Process equivalence D.12.5.2 Criteria for process equivalence |
82 | D.12.5.3 Determination of process equivalence D.12.5.4 Process analysis and evaluation D.12.5.5 Evaluation of preconditioning or aeration areas D.12.5.6 Evaluation of sterilization chamber performance |
83 | D.12.5.7 Microbiological evaluation D.12.5.8 Results evaluation |
84 | D.12.5.9 Maintenance of equivalence D.12.5.10 Documentation D.12.5.11 Product D.12.5.11.1 Product family |
85 | D.12.5.11.2 Determination of adverse effects to product D.12.5.11.3 Determination of product design effects |
86 | D.12.5.11.4 Determination of product material and characteristics effects D.12.5.11.5 Determination of sterile barrier system effects D.12.5.11.6 Determination of load configuration effects D.12.5.11.7 Conclusions of product adoption evaluation D.13 Guidance on Annex A — Determination of lethal rate of the sterilization process — Biological indicator/bioburden approach D.13.1 [A.1] General |
88 | D.13.2 [A.2] Procedure |
89 | D.14 Guidance on Annex B — Conservative determination of lethal rate of the sterilization process — Overkill approach D.14.1 [B.1] General |
90 | D.14.2 [B.2] Procedure |
91 | Annex E: Single Lot Release E.1 General E.2 Procedure |
93 | Bibliography |